AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Janusmart M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Roussel Laboratories Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Janusmart M 50mg/500mg Tablet

Duo-Control 50mg/500mg tablets effectively manage elevated blood glucose in type 2 diabetes patients. This dual-action medication helps mitigate serious diabetic complications like vision impairment and kidney disease, potentially lowering heart attack and stroke risk. Duo-Control 50mg/500mg may be used independently or in conjunction with other anti-diabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Consuming it with meals minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinue only under physician guidance. Adherence to your prescribed diet and exercise plan is crucial for diabetes management. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and throat irritation. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; learn to identify and manage this. Consult your doctor before use if you have pre-existing kidney, liver, or heart conditions, pancreatic issues, or consume excessive alcohol. Pregnant or lactating individuals should seek medical advice. Inform your doctor of all other medications you're taking for potential interactions. Alcohol consumption should be limited due to its blood sugar-lowering effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Janusmart M 50mg/500mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Janusmart M 50mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Janusmart M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Janusmart M 50mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Consume this medicine with a meal.

Common Side effects of Janusmart M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Janusmart M 50mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Janusmart M 50mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

How Janusmart M 50mg/500mg Tablet works:

Janusmart M, a 50mg/500mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action synergistically improves glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Janusmart M 50mg/500mg Tablet is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Janusmart M 50mg/500mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Janusmart M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Caution is advised when administering Janusmart M 50mg/500mg tablets to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. Janusmart M 50mg/500mg tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is prudent during treatment.

LiverLiverUNSAFE

The use of Janusmart M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided unless specifically directed by a physician. Medical consultation is recommended.

What if you forget to take Janusmart M 50mg/500mg Tablet :

Should you forget a dose of Janusmart M 50mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Janusmart M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Janusmart M 50mg/500mg Tablet

Janusmart M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Janusmart M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Janusmart M 50mg/500mg Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Janusmart M 50mg/500mg Tablet is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Janusmart M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as MALA—Metformin-associated lactic acidosis), is a potential side effect of Janusmart M 50mg/500mg Tablet. This occurs due to elevated blood lactic acid levels. Because it's rare, metformin is avoided in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Janusmart M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Janusmart M 50mg/500mg Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Janusmart M 50mg/500mg Tablet is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Janusmart M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Janusmart M 50mg/500mg Tablets can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect, linked to metformin, necessitates avoiding the medication in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Janusmart M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Janusmart M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Janusmart M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Janusmart M 50mg/500mg Tablet is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Janusmart M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Janusmart M 50mg/500mg Tablets can cause lactic acidosis (MALA, Metformin-associated lactic acidosis), a serious medical condition involving high blood lactic acid levels. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Janusmart M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Janusmart M 50mg/500mg Ta...
333